PARIS and LEXINGTON, Mass – August 3, 2021 – As part of Sanofi’s endeavor to accelerate the application of messenger RNA (mRNA) to develop therapeutics and vaccines, the company has entered into a ...
Over the past few years, Sanofi has increasingly upped its bet that vaccines and therapies based on messenger RNA (mRNA) technology could transform the drug industry. Now, the firm is going all in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results